Showing 1,001 - 1,020 results of 11,314 for search '"eventing"', query time: 0.09s Refine Results
  1. 1001
  2. 1002
  3. 1003
  4. 1004
  5. 1005
  6. 1006
  7. 1007

    Dynamical Complexity Transitions During High‐Intensity Long Duration Continuous Auroral Activities (HILDCAA) Events: Feature Analysis Based on Neural Network Entropy by I. A. Oludehinwa, A. Velichko, B. O. Ogunsua, O. I. Olusola, O. O. Odeyemi

    Published 2023-09-01
    “…Neural Network Entropy (NNetEn) was used to capture the dynamical complexity transitions during these sporadic events. The NNetEn was able to decipher the distinct dynamical features associated with the emergence of HILDCAA and the geomagnetically quiet periods. …”
    Get full text
    Article
  8. 1008
  9. 1009

    Combining extracellular matrix proteome and phosphoproteome of chickpea and meta‐analysis reveal novel proteoforms and evolutionary significance of clade‐specific wall‐associated events in plant by Kanika Narula, Arunima Sinha, Pooja Choudhary, Sudip Ghosh, Eman Elagamey, Archana Sharma, Atreyee Sengupta, Niranjan Chakraborty, Subhra Chakraborty

    Published 2024-03-01
    “…Although this incredible diversity has to some extent been investigated at protein level, extracellular phosphorylation events and molecular evolution of ECM proteoform families remains unexplored. …”
    Get full text
    Article
  10. 1010

    Event-Triggered Stability Analysis of Semi-Markovian Jump Networked Control System with Actuator Faults and Time-Varying Delay via Bessel–Legendre Inequalities by Hongqian Lu, Chaoqun Guo, Yue Hu, Wuneng Zhou

    Published 2019-01-01
    “…The system dynamic is optimized while the network resource is saved by introducing an improved static event-triggered mechanism. For deriving a less conservative stability criterion, the Bessel–Legendre inequalities approach is employed to the stability analysis and plays a major role. …”
    Get full text
    Article
  11. 1011

    Fournier Gangrene Associated with Sodium-Glucose Cotransporter-2 Inhibitors: A Pharmacovigilance Study with Data from the U.S. FDA Adverse Event Reporting System by Yang Hu, Ziyu Bai, Yan Tang, Rongji Liu, Bin Zhao, Jian Gong, Dan Mei

    Published 2020-01-01
    “…This study is aimed at presenting data supplementary to existing studies by analysing postmarketing adverse event reports in the FDA Adverse Events Reporting System (FAERS) database. …”
    Get full text
    Article
  12. 1012

    Characteristics, Incidence, and Management of Immune Checkpoint Inhibitors Related Cardiovascular Adverse Events in Real-World Practice-A Retrospective Study in Chinese Han Population by Wang RH, Chen Y, Lou YL, Lu YL, Xu HM

    Published 2025-02-01
    “…Rong-Hua Wang,1 Yin Chen,1 Ya-Ling Lou,1 Yu-Liang Lu,2 Hui-Min Xu3 1Department of Pharmacy, HuZhou Central Hospital (The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University), Huzhou, People’s Republic of China; 2Department of Cardiology, HuZhou Central Hospital (The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University), Huzhou, People’s Republic of China; 3Department of Pharmacy, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of ChinaCorrespondence: Rong-Hua Wang, Department of Pharmacy HuZhou Central Hospital (The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University), No. 1558 Sanhuan North Road, Wuxing District, Huzhou, Zhejiang, 313000, People’s Republic of China, Email legend.blue@163.com Hui-Min Xu, Department of Pharmacy Second Affiliated Hospital, Zhejiang University School of Medicine, No. 88 Jiefang Road, Shangcheng District, Hangzhou, Zhejiang, 310009, People’s Republic of China, Email xuhuimin78@zju.edu.cnPurpose: This study aimed to elaborate on the incidence, clinical features, and management of immune checkpoint inhibitors (ICIs) related cardiovascular adverse events (CVAEs) in real-world practice.Patients and Methods: We performed a retrospective chart review study on patients receiving at least one dose of ICI therapy at a Chinese tertiary hospital from March 2020 to March 2021. …”
    Get full text
    Article
  13. 1013

    Development and Validation of a Nomogram for Predicting Long-Term Net Adverse Clinical Events in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention by Junyan Zhang, Zhongxiu Chen, Ran Liu, Yuxiao Li, Hongsen Zhao, Yanning Li, Minggang Zhou, Hua Wang, Chen Li, Li Rao, Yong He

    Published 2025-01-01
    “…Subsequently, a prediction model for 1-year net adverse clinical events (NACEs)-free survival was developed using a multivariable Cox regression model, and a nomogram was constructed. …”
    Get full text
    Article
  14. 1014
  15. 1015
  16. 1016
  17. 1017

    Sex differences of fall-risk-increasing drugs in the middle-aged and elderly: a descriptive, cross-sectional study of FDA adverse event reporting system by Ying Zhao, Yuke Zhong, Liuqing Wu, Jiao Yan, Weitao Lu

    Published 2024-11-01
    “…Abstract It’s well known that sex is a risk factor for the occurrence of adverse events (AEs), most of which have found sex differences. …”
    Get full text
    Article
  18. 1018
  19. 1019
  20. 1020